AcelRx Pharmaceuticals, Inc.
(NASDAQ : ACRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
2.51%14.7014.1%$263.94m
SHPGShire PLC Sponsored ADR
1.89%147.370.4%$196.60m
PRGOPerrigo Co. Plc
-1.35%85.836.6%$138.72m
MNKMallinckrodt Plc
-0.31%22.3818.5%$115.94m
SAGESAGE Therapeutics, Inc.
0.01%85.6811.9%$89.57m
JAZZJazz Pharmaceuticals Plc
0.26%133.872.2%$75.98m
ENDPEndo International Plc
3.29%7.548.9%$65.52m
ICPTIntercept Pharmaceuticals, Inc.
1.39%60.7322.0%$53.20m
UTHRUnited Therapeutics Corporation
1.15%123.0214.5%$49.84m
PCRXPacira Pharmaceuticals, Inc.
1.90%40.2510.7%$40.63m
MDCOMedicines Company
1.32%31.4322.1%$38.62m
ICLRICON Plc
1.36%117.254.1%$37.65m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.42%115.887.6%$35.91m
ADMSAdamas Pharmaceuticals, Inc.
2.60%28.4116.9%$33.20m
PTLAPortola Pharmaceuticals, Inc.
0.26%49.287.8%$33.10m

Company Profile

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. Its product candidates is comprised of DSUVIA, and ZALVISO, which both contains sufentanil as a therapeutic ingredient. The company was founded by Thomas A. Schreck and Pamela P. Palmer on July 13, 2005 and is headquartered in Redwood City, CA.